# Galantamine and CBT4CBT Pilot to Prevent Relapse.

> **NCT03547622** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 6 (actual)

## Conditions studied

- Methadone or Buprenorphine Detoxoxification

## Interventions

- **DRUG:** MAT taper with galantamine
- **DRUG:** MAT taper with placebo

## Key facts

- **NCT ID:** NCT03547622
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547622, "Galantamine and CBT4CBT Pilot to Prevent Relapse.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03547622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*